Co-Diagnostics (CODX) 10-Q2024 Q1 Quarterly report

Filed: 9 May 24, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: agent, app, ASU, attainment, beginning, biopsy, cancer, CoSara, cup, disbursement, entity, epidemic, evolving, GAAP, global, guidance, installed, IVD, locate, milestone, mobile, mutated, omitted, order, Pro, prospectively, reconciliation, retrospectively, similarly, spread, standard, submission, Topic, utilized

Removed: ACI, acquired, add, adjustment, advisory, announced, approximated, arrangement, assumed, assured, attributable, borrowing, Brent, calculating, capacity, capitalized, case, charge, classified, classifying, collateral, collectability, combined, commencement, commercial, comparing, component, comprise, computed, conversion, credit, creditworthy, debt, deposit, depreciation, determining, develop, direct, discontinue, dividing, Dr, economic, event, exceeded, exclude, exercised, experienced, expired, exposed, extend, federally, fixed, fluctuate, foregoing, forfeited, forfeiture, founder, Goodwill, hand, IdMo, impaired, impairment, implicit, improved, inception, incremental, inherently, initially, insured, intend, investee, large, licensing, longer, maintenance, margin, maturity, maximum, measuring, office, original, percentage, periodic, placement, position, present, private, productive, profitable, Recoverability, recoverable, recovery, registering, registration, relating, remuneration, renewal, require, requirement, requisite, response, ROU, Satterfield, separate, service, shelf, space, statement, summary, supportable, suspend, tested, trading, transferred, typically, undiscounted, unpredictable, unrealized, volume

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated CODX transcripts

CODX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S. C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Co-Diagnostics, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Dwight H. Egan, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

	(1)	The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2024	By:	/s/ Dwight H. Egan
		Dwight H. Egan
		Chief Executive Officer and Principal Executive Officer